Tianjin Tianyao Pharmaceuticals' high P/E ratio is alarming ...
Tianjin Tianyao Pharmaceuticals' high P/E ratio is alarming due to its three-year growth being lower than market predictions. If recent earnings trends persist, shareholders' investments could be at risk and potential investors may pay an excessive premium.
Earnings Not Telling The Story For Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE:600488)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment